The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial - Judge, Parminder K.; Tuttle, Katherine R; Staplin, Natalie; Hauske, Sibylle J.; Zhu, Doreen; Sardell, Rebecca; Cronin, Lisa; Green, Jennifer B; Agrawal, Nikita; Arimoto, Ryoki; Mayne, Kaitlin J; Sammons, Emily; et al. (Nephrology, dialysis, transplantation, 2025)
Online veröffentlicht: 12. November 2024